Vanguard reports 2.66M Axogen shares (5.12%)
Vanguard Capital Management reports beneficial ownership of 2,659,776 shares of Axogen Inc common stock, representing 5.12% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vanguard Capital Management reports beneficial ownership of 2,659,776 shares of Axogen Inc common stock, representing 5.12% of the class.
The Schedule 13G states Vanguard has sole voting power for 368,213 shares and sole dispositive power for 2,659,776 shares. The filing attributes holdings to Vanguard funds and managed accounts. The form is signed 04/29/2026.
Key Figures
Key Terms
beneficially owned regulatory
sole dispositive power regulatory
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard Capital Management report in AXGN?
What voting and disposition powers does Vanguard hold for AXGN?
When was the Schedule 13G for AXGN signed and filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.